Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicity.
about
Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccinesAntiviral B cell and T cell immunity in the lungs.Respiratory syncytial virus: current and emerging treatment options
P2860
Affinity-purified respiratory syncytial virus antibodies from intravenous immunoglobulin exert potent antibody-dependent cellular cytotoxicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Affinity-purified respiratory ...... pendent cellular cytotoxicity.
@en
Affinity-purified respiratory ...... pendent cellular cytotoxicity.
@nl
type
label
Affinity-purified respiratory ...... pendent cellular cytotoxicity.
@en
Affinity-purified respiratory ...... pendent cellular cytotoxicity.
@nl
prefLabel
Affinity-purified respiratory ...... pendent cellular cytotoxicity.
@en
Affinity-purified respiratory ...... pendent cellular cytotoxicity.
@nl
P2093
P2860
P50
P1433
P1476
Affinity-purified respiratory ...... pendent cellular cytotoxicity.
@en
P2093
Francois Simon
Michel D Kazatchkine
Olivier Touzelet
Severine Mercier-Delarue
Soulaima Chamat
Srinivas V Kaveri
P2860
P304
P356
10.1371/JOURNAL.PONE.0069390
P407
P577
2013-07-19T00:00:00Z